ArticleOncogene2020

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors.

Yezi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.